All Type of News
KFDA to cancel drug registrations without production.
A growing number of drugs found registration without actual production according to the National Assembly report. 246 drugs out of the total 490 items proven of its bio-equivalency in 2003 have not been produced at al...
Government-funded R&D investment totaled 72.8 billion won for 4 years
The Ministry of Health and Welfare said it has invested a total of 72.8 billion won for 386 R&D new drug projects since 2001, according to data submitted to the National Assembly during the recent parliamentary inspec...
Separation of drug dispensing from medical practice is in right track.
The implementation of a new system of separating drug dispensing from medical practice since 2000 has been well institutionalized, according to data submitted to the National Assembly by the Ministry of Health and Wel...
National Assembly to issue on OTC drug sale at general stores.
In the parliamentary inspection to the government administration (KFDA) on Oct. 5, the subject of the OTC drug sale at other stores than pharmacies became a hot issue implicated with the drug safety in connection with...
SK Chemical/Pharm announce Korean launch of frovatripan.
SK Chemical and SK Pharm said on October 3 that they signed an exclusive agreement with UK-based Vernalis Co. for the distribution of anti-migraine drug Migard (frovatriptan succinate) in Korea, noting that the launch...
KFDA approves amlodipine adipate
CJ Corporation said its new amlodipine adipate (brandname: Amlosta tablet) has been approved for marketing by the Korea Food and Drug Administration, based on the results of local Phase III clinical trials involving 2...
FTC to review unfair provisions of Zuellig's distribution agreement.
The pharmaceutical wholesale circle seems to get relief from the Zuellig's trade pressure.
According to a reliable source from the pharmaceutical wholesale industry on Oct. 6, the Korea Pharmaceutical Wholesale As...
Young breast cancer patients in high recurrence and death risk.
A study reported a far higher recurrence and death risk for young breast cancer patients in Korea.
In the survey on the survival and recurrent rates of breast cancer patients in Korea conducted by Prof. Ahn Se-heon...
Yungjin Pharm to market HEXAL’s Amlocard tablet
Yungjin Pharm said on October 4 it has obtained exclusive marketing and distribution rights to HEXAL’s Amlocard (amlodipine besylate) tablet for the treatment of hypertension in Korea.
Amlocard tablet, which was ap...
MSD Korea announced urgent recall of Vioxx.
MSD Korea instructed all physicians about an urgent recall of Vioxx via a phone or fax including official letters far aggressively for a prompt withdrawal of the stocks from the market place except wholesalers where p...
